Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2011

View Archived Issues

Phase II study assesses BAF-312 in relapsing-remitting MS

Imaging agent [123I]-BZM-055 assessed in nonhuman primates

Lostam BioPharmaceutical presents monoclonal antibodies against P. aeruginosa flagellin

Scientists in Sweden identify new biomarker for disease activity in MS

Natural plant-derived product inhibits proliferation of gastric cancer cells

Novel sterol O-acyltransferase 2 inhibitors synthesized in Japan

New HIV integrase inhibitors presented by Critical Outcome Technologies

Johnson & Johnson submits sNDA to FDA for Nucynta ER

Circadian Technologies clear to start clinical development of VGX-100

Actelion Pharmaceuticals discloses novel antibacterials

Sanofi presents new Met inhibitors

Galena Biopharma focuses on late-stage targeted cancer drug development

Piramal Life Sciences synthesizes new cytokine inhibitors

Takeda Pharmaceutical prepares novel histamine H3 receptor antagonists

TNF-Kinoid shows promise in phase IIa trial

CytRx reports further on phase Ib/II study of INNO-206

FDA approves Pacira Pharmaceuticals' Exparel

European orphan drug status for Celldex Therapeutics' rindopepimut

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

MorphoSys and Shionogi extend HuCAL research partnership

Phase II study of CK-2017357 advances

NVB-302 enters clinical testing

Infinity Pharmaceuticals begins two studies of IPI-145

FDA approves Xience Prime stent

Avanir Pharmaceuticals submits MAA for Nuedexta

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....